Who owns the BT BIOXCEL THERAPEUTICS trademark?

The BT BIOXCEL THERAPEUTICS trademark is owned by Bioxcel Therapeutics, Inc..

What is the serial number for BT BIOXCEL THERAPEUTICS?

The USPTO serial number for BT BIOXCEL THERAPEUTICS is 88885185.

What is the registration number for BT BIOXCEL THERAPEUTICS?

BT BIOXCEL THERAPEUTICS is registered under USPTO registration number 6359361.

BTB

USPTO Trademark Record

REGISTERED

BT BIOXCEL THERAPEUTICS

Q: What class is the BT BIOXCEL THERAPEUTICS trademark registered in?

The BT BIOXCEL THERAPEUTICS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 88885185·Reg 6359361·Filed Apr 23, 2020

Owner Bioxcel Therapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

BT BIOXCEL THERAPEUTICS (Serial No. 88885185), Registration No. 6359361, is a registered US trademark filed on Apr 23, 2020 by Bioxcel Therapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

Renewal window: May 25, 2027214 days remaining

Mark Intelligence

BT BIOXCEL THERAPEUTICS (Reg. #6359361) is a registered US trademark that has been protecting its owner, Bioxcel Therapeutics, Inc., since 2020. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Apr 23, 2020

SERIAL

88885185

REG#

6359361

REGISTERED

May 25, 2021

Owner

Applicant

Bioxcel Therapeutics, Inc.

Entity

Corporation

State

Address

555 Long Wharf Drive, 12th Floor, New Haven, CT, 06516

Country

Attorney

NameBrendan J. Hughes

Law firm

Brendan J. Hughes COOLEY LLP

Address

1299 PENNSYLVANIA AVENUE, SUITE 7000, WASHINGTON, DC 20004, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateApr 23, 2020

Serial Number88885185

Registration No.6359361

Registration DateMay 25, 2021

Status DateMay 25, 2021

Published for OppositionMar 09, 2021

Mark TypeStandard characters

Status DescriptionLive and registered

Filing Signals

FILED

2020

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

First use anywhere: Feb 28, 2017

First use in commerce: Feb 28, 2017

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Feb 28, 2017

First use in commerce: Feb 28, 2017

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

15 events

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

May 25, 2026

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

REGISTERED-PRINCIPAL REGISTER

May 25, 2021

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Mar 09, 2021

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 09, 2021

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 17, 2021

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 01, 2021

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 26, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 25, 2021

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 25, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION WRITTEN

Jul 23, 2020

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Jul 23, 2020

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jul 23, 2020

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Jul 16, 2020

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 04, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Apr 27, 2020

NEW APPLICATION ENTERED

BT BIOXCEL THERAPEUTICS

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Bioxcel Therapeutics, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Brendan J. Hughes

Resources

Company